# Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs

> **NCT00477230** · PHASE3 · TERMINATED · sponsor: **CardioFocus** · enrollment: 64 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Endoscopic Ablation System
- **DRUG:** Standard Anti-arrhythmic Drug (AAD) Therapy

## Key facts

- **NCT ID:** NCT00477230
- **Lead sponsor:** CardioFocus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Study terminated based on decision of Sponsor.
- **Last updated:** 2012-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477230, "Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00477230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*